ORLANDO, Fla. — The topical Janus tyrosine kinase (JAK) 1/2 inhibitor ruxolitinib improved itching and nodules in patients with prurigo nodularis (PN) significantly better than a vehicle within a week after starting therapy, with improvements continuing out to 3 months, in a global phase 3 clinical trial...
???? Are You a Music Artist Ready to Be Heard? ????
It’s time to stop playing around and get your music on real radio. Join a platform that truly supports artists and gives you the exposure you deserve.
SugarWaterRadio is changing the game—one song at a time.
Get real airplay, real listeners, and real results.
???? Submit your music now at SugarWaterRadio.com
Let’s make your dream a reality.
CLICK HERE & TURN UP YOUR FUTURE! ????
Copyright © 2023 swsports. All Rights Reserved